|
What
is IMS Disease Analyzer?
IMS Disease
Analyzer has the powerful ability to track patients, diseases
and therapies over time, this gives important insights about
what happens before during and after a medical intervention.
Based
on real life observational data, IMS Disease Analyzer enables
clients to optimise:-
 |
portfolio
management by mapping future market potential |
|
marketing
effectiveness by understanding patient profiles and competitor
activity |
|
research
and development decisions by understanding disease incidence
and prevalence |
IMS Disease
Analyzer can be used for single or multi-county analyses from
UK, Germany, France and Austria.
IMS
Disease Analyzer - Key Facts
|
The
largest, most comprehensive and powerful patient database
in Europe:- |
|
4
countries , 9.5 million patient records from 2000 office
based doctors |
|
Longitudinal
analyses of patient treatment |
|
High
quality data, updated monthly |
|
Services
for marketing research, health outcomes, pharmaco-epidemiology,
drug safety, regulatory submissions |
|
Tailored
solutions including client based workstations, customised
studies and consultancy |
Rationale
for IMS Disease Analyzer
MEDIPLUS
is the only multi-country database that can track individual
patients over time providing insights into:-
|
|
Disease
evolution and progression
|
|
Time
taken to diagnosis and treatment
|
|
Patient
compliance and persistence
|
|
Tests
used for diagnosis (and frequency and results)
|
|
Number
of visits taken to treat
|
|
Number
of patients with risk factors (i.e. market potential)
|
|
Number
of failed treatments (switching)
|
|
Reason
for failed treatments (inpatients notes)
|
Continue
|
